Skip to content

Bruno Revol

4 papers in the library · 11 citations · publishing 2022-2024

Papers

Sort Most recent Most cited

Smartphone swabs as an emerging tool for toxicology testing: a proof-of-concept study in a nightclub.

Clinical chemistry and laboratory medicine August 27, 2024 Théo Willeman, Justine Grunwald, Marc Manceau et al. 3 citations

Smartphones have become everyday objects on which the accumulation of fingerprints is significant. In addition, a large proportion of the population regularly uses a smartphone, especially younger people. The objective of this study was to evaluate smartphones as a new matrix for toxico-epidemiology. This study was conducted during two separate events (techno and trance) at an electronic music...

DOI: 10.1515/cclm-2024-0242 (opens in new tab) Full text (opens in new tab) New psychoactive substances Recreational drugs Smartphones Drug testing +5

NPAideS: a drug-checking study among 3-methylmethcathinone (3-MMC) users.

Harm Reduction Journal July 28, 2023 Théo Willeman, Nathan Grundig, Christine Pochon et al. 8 citations

3-methylmethcathinone (3-MMC) has been available on the European drug market for several years, but an increase in its availability seems to have occurred around 2020, associated with reports of harm and death. We aimed to analyze the composition of the supposed 3-MMC samples purchased and its concordance with the assumed composition of the drug. A prospective multicenter (n = 6) study was...

DOI: 10.1186/s12954-023-00836-4 (opens in new tab) Full text (opens in new tab) 3-methylmethcathinone Chemsex Drug checking Harm reduction

Association between NMDAR antagonists, drug abuse and dependence: A disproportionality analysis from the WHO pharmacovigilance database.

British Journal of Clinical Pharmacology November 1, 2022 Bruno Revol, Maryse Lapeyre-Mestre, Nathalie Fouilhé Sam-Lai et al.

Ketamine and dextromethorphan are widely abused psychoactive substances. Inhibition of N-methyl-d-aspartate receptors (NMDARs) results in neurobehavioural effects including hallucinations, "out of body" sensations and dissociative effects. However, little is known about a possible extended addictive class effect linked to pharmacologically-related amino-adamantane derivatives (e.g., amantadine...

DOI: 10.1111/bcp.15430 (opens in new tab) Full text (opens in new tab) Dependence Nmda-r antagonists Vigibase® Addictovigilance +1

[Pharmacology of cannabidiol: Red flags, consequences and risks in humans].

The´rapie 2022 Joëlle Micallef, Anne Batisse, Bruno Revol

Scientific knowledge about cannabidiol (CBD) demonstrates that CBD is a substance that is not pharmacologically inert. If it does not act efficiently on cannabinoid receptors (those where tetrahydrocannabidol [THC] is fixed), it acts on brain receptors, especially on dopamine and serotonin receptors, making it a psychoactive product in its own right. Its consumption can thus have psychoactive...